Skip to main content
Quest Diagnostics

Inhalant Allergen Sensitization: Prevalence, Risk Factors, and Geographic Variation in the United States

Inhalant Allergen Sensitization: Prevalence, Risk Factors, and Geographic Variation in the United States

Authors: Kwong K, Chen Z, Scott L, Hilborne LH

Citation: Int Arch Allergy Immunol. 2025 May 28:1-21. doi: 10.1159/000545508. Online ahead of print.

Specialties:  Immunology, Allergy, Infectious disease

Related content

Publication
Optimizing Identification of Allergic Sensitization to Seasonal Inhalant Allergens in the USA: Implications for Constructing Optimal Panels to Evaluate Patients with Allergy
Conference Presentation
Optimal Identification of Allergic Sensitization Toward Seasonal Inhalant Allergens in the United States
On-Demand Webinar
Interpretation of Respiratory Allergy Results for Patient Management
On-Demand Webinar
The Nuts and Bolts of Food Allergy Component Testing

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.